The Beauty Health Company (NASDAQ:SKIN) Receives $2.32 Average Target Price from Brokerages

The Beauty Health Company (NASDAQ:SKIN) has received an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $2.32.

SKIN has been the topic of several research analyst reports. Canaccord Genuity Group reduced their target price on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Zacks Research raised Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. Jefferies Financial Group reissued a “hold” rating and set a $1.60 target price on shares of Beauty Health in a research note on Wednesday, January 14th. TD Cowen reduced their target price on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. Finally, Benchmark reissued a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th.

Hedge Funds Weigh In On Beauty Health

Several hedge funds have recently made changes to their positions in the business. Capricorn Fund Managers Ltd purchased a new position in shares of Beauty Health during the first quarter valued at approximately $17,270,000. Mirabella Financial Services LLP increased its stake in shares of Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after buying an additional 2,734,728 shares during the period. Woodline Partners LP raised its position in shares of Beauty Health by 255.9% in the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after acquiring an additional 4,263,997 shares in the last quarter. Millennium Management LLC raised its position in shares of Beauty Health by 127.0% in the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after acquiring an additional 3,225,668 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares in the last quarter. 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Price Performance

NASDAQ SKIN opened at $0.58 on Wednesday. The company has a debt-to-equity ratio of 4.37, a current ratio of 1.79 and a quick ratio of 1.48. The stock has a market capitalization of $74.11 million, a PE ratio of -3.41 and a beta of 1.12. Beauty Health has a 1 year low of $0.57 and a 1 year high of $2.69. The business’s 50-day moving average is $0.98 and its 200 day moving average is $1.24.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The business had revenue of $64.91 million during the quarter, compared to analyst estimates of $66.28 million. Sell-side analysts forecast that Beauty Health will post -0.18 earnings per share for the current year.

Key Beauty Health News

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Q1 adjusted loss per share of $0.05 beat the consensus estimate of a $0.09 loss, showing better-than-expected profitability versus Wall Street expectations.
• Positive Sentiment: The company said it sees Q2 2026 revenue of $72 million to $77 million, which is roughly in line with estimates and suggests some near-term stability.
• Neutral Sentiment: Investor attention is also on the company’s first-quarter earnings call and conference materials for more detail on demand trends, margins, and the outlook for its Hydrafacial brand. SkinHealth Systems Reports First Quarter 2026 Financial Results
• Negative Sentiment: Q1 revenue of $64.91 million missed analyst expectations of $66.28 million, which points to softer-than-expected sales performance.
• Negative Sentiment: The company also guided full-year 2026 revenue to $280 million-$295 million, below the consensus estimate of $296.5 million, signaling slower growth ahead.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.